Michael Mendelsohn
CIK: 0001591109
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FHTX
Foghorn Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Mendelsohn Michael
Mendelsohn Michael (SEC CIK 0001591109) files insider reports with the SEC as Director of Foghorn Therapeutics Inc. (FHTX).
Signal8 holds 2 ownership filings by Mendelsohn Michael, all Form 4s, filed between Jun 17, 2025 and Jun 25, 2026. Those filings report 2 transactions, from Jun 17, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mendelsohn Michael's filings is in WATERTOWN, MA.
Recent filings by Mendelsohn Michael
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- SMITH IAN F, Director